IceCure Files for Regulatory Approval of ProSense® Cryoablation System in China
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
GlobalData on MSN3d
IceCure submits application to China’s NMPA for cryoablation system approval
IceCure Medical has submitted a regulatory filing to China's National Medical Products Administration (NMPA) seeking the ...
IceCure Medical files for approval of ProSense Cryoablation System in China
IceCure Medical (ICCM) has submitted a regulatory filing with China’s National Medical Products Administration for the approval of its ProSense ...
Le Lézard4h
Interventional Oncology Market to Hit USD 4.24 Billion by 2029 with 9.0% CAGR | MarketsandMarketstm
The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ 2.75 Billion in 2024 and an impressive US$ 4.24 Billion by 2029. The ...
Science Daily3d
Lung Disease News
Jan. 13, 2025 — Scientists have found that a test to detect circulating tumor DNA can predict lung cancer ... Lung Cancer Test Predicts Survival in Early Stages Better Than Current Methods Jan ...
Cryoablation Devices Market To Hit USD 1295.34 Mn By 2032, Driven By Growing Demand For Minimally Invasive Treatments
Cryoablation Devices market set for 10.26% CAGR growth from 2024-2032, fueled by rising cancer and cardiovascular disease prevalence. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email us here Visit ...